Related Experiment Videos
The pacer-cardioverter-defibrillator: function and clinical experience
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
Journal of Cardiovascular Electrophysiology
|January 1, 1995
Summary
The pacer-cardioverter-defibrillator (PCD) effectively detects and treats ventricular arrhythmias using programmable zones and tiered therapies. Advanced sensing minimizes false detections, ensuring reliable performance for patients with heart rhythm disorders.
Area of Science:
- Cardiology
- Biomedical Engineering
- Electrophysiology
Background:
- Ventricular arrhythmias pose a significant risk for sudden cardiac death.
- Pacing and defibrillation devices are crucial for managing these conditions.
- Accurate detection and effective treatment are paramount for patient outcomes.
Purpose of the Study:
- To review the comprehensive function of the pacer-cardioverter-defibrillator (PCD).
- To detail the mechanisms for detecting ventricular arrhythmias and preventing overdetection.
- To explain the tiered therapeutic options and shock delivery systems.
Main Methods:
- Review of existing literature on pacer-cardioverter-defibrillator technology.
- Analysis of device programming features for arrhythmia detection (onset/stability modifiers).
- Examination of sensing circuitry, including auto-adjusting sensitivity and exponential decay.
- Description of tiered therapy options: antitachycardia pacing, cardioversion, and defibrillation.
- Discussion of lead system configurations (two-lead vs. three-lead) and shock delivery modes.
- Evaluation of telemetered marker channel and electrogram for device assessment.
Main Results:
- The PCD utilizes programmable zones with modifiers to accurately detect ventricular arrhythmias while reducing false positives from sinus tachycardia and atrial fibrillation.
- Advanced sensing circuitry with auto-adjusting sensitivity and exponential decay enables detection of low-amplitude ventricular fibrillation without T-wave oversensing.
- Tiered therapy, including antitachycardia pacing and programmable cardioversion/defibrillation shocks, offers flexible treatment strategies.
- Programmable shock delivery (single pathway, simultaneous, or sequential) adapts to different lead system configurations.
- Telemetered data aids in effective device implantation and follow-up monitoring.
Conclusions:
- The pacer-cardioverter-defibrillator (PCD) provides sophisticated and reliable detection of ventricular arrhythmias.
- Its tiered therapeutic approach and advanced sensing capabilities enhance treatment efficacy and safety.
- The device's features facilitate accurate assessment and management of cardiac arrhythmias.